Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3123 results found
Expand All
Apply All
3123 results found

Good Day BIO: Escaping the food allergy prison
Share
Good Day BIO Newsletter  •  October 12, 2021
A new episode of the I am BIO Podcast explores how biotech is making food safer for people with allergies or sensitives. And since it’s Hispanic Heritage Month, we take a closer look at COVID-19 disparities and vaccine hesitancy in the Hispanic and Latinx community. (832 words, 4 minutes, 9 seconds)
Read More

112 Enablement: What to Watch Out For
Share
Policy

BIO IP Counsels Committee Webinar
Series – Episode 3
Share
Policy

Good Day BIO: Narcan inventor saves another life – in person
Share
Good Day BIO Newsletter  •  October 11, 2021
Start your week with this must-watch story of a BIO Board member who saved a stranger’s life with his own invention. Meanwhile, the government’s quiet today but we take a look at climate contingency plans released by 26 government agencies last week—and the important role for biotech. (661 words, 3 minutes, 18 seconds)  RIP “biotech giant” Alan C. Mendelson, who passed away over the weekend. The former BIO Board member was “one of the all-time great legal minds in biotech,” as former chairman Dr. Jeremy Levin put it. Mendelson was recently appointed to the Boards of Coherus BioSciences and the National Kidney Foundation. Our thoughts are with his family and friends.
Read More

Congressional Letter to Administration on Importance of Animal Biotechnology
Share
Letters, Testimony & Comments  •  October 8, 2021
As you know, several challenges facing the agriculture industry and our communities have emerged or intensified in recent years. Zoonotic disease, climate change, and a growing global population require us to consider new solutions to protect our food supply and sustainably meet demand. Ongoing research and existing innovations in animal genetics show great promise in addressing these challenges. However, an efficient, risk and science-based regulatory system that can create a safe, predictable path to market is imperative to capitalizing on these solutions. We believe the existing U.S. regulatory process for the review of animals developed or improved through biotechnology requires significant improvement to meet that standard, and we encourage the U.S. Department of Agriculture (USDA) and Food & Drug Administration (FDA) to continue working with each other and with other relevant federal partners to appropriately modernize this important process.
Read More

Good Day BIO: Animal biotech is exciting – let's get it to market
Share
Good Day BIO Newsletter  •  October 8, 2021
The Senate voted to raise the debt ceiling and bipartisan House members are calling on the administration to improve the regulatory process for animal biotech. We also look at why the Merck-Ridgeback COVID-19 pill is an example of the importance of Bayh-Dole and America’s innovation ecosystem. (990 words, 4 minutes, 57 seconds)
Read More

Good Day BIO: This could be the first oral COVID therapeutic
Share
Good Day BIO Newsletter  •  October 7, 2021
The U.S. Trade Representative made a major policy speech yesterday on the administration’s approach to China—we tell you what biotech needs to know. Also, a recent report looks at COVID-19’s impact on older Hispanic adults and provides policy recs for addressing disparities. (777 words, 3 minutes, 53 seconds) The BIO IMPACT Webinar Series begins today with a look at sustainability accounting—get the details and join us at 1 PM ET!
Read More

Good Day BIO: Mental Illness Awareness Week
Share
Good Day BIO Newsletter  •  October 7, 2021
It’s Mental Illness Awareness Week—here’s more on why it’s so important to destigmatize mental health care, and where you can find resources. Plus, a recent paper found a low-carbon economy is cheaper than climate change—and luckily, we already have many tools available to help the transition. (722 words, 3 minutes, 36 seconds) P.S. BIO’s Dr. Michelle is speaking at an Axios virtual event today on ensuring access to quality health care—watch the livestream starting at 12:30 PM ET!
Read More

Good Day BIO: Calculating the climate benefits of biotech – and a TRIPS update
Share
Good Day BIO Newsletter  •  October 6, 2021
How can we calculate the benefits of our sustainability practices—and ensure biotech innovations can be widely adopted? Experts provided insight during BIO IMPACT yesterday. We also have an update on where things stand on the TRIPS waiver. (902 words, 4 minutes, 30 seconds)
Read More

Good Day BIO: USTR's China Strategy
Share
Good Day BIO Newsletter  •  October 5, 2021
The U.S. Trade Representative made a major policy speech yesterday on the administration’s approach to China—we tell you what biotech needs to know. Also, a recent report looks at COVID-19’s impact on older Hispanic adults and provides policy recs for addressing disparities. (777 words, 3 minutes, 53 seconds) The BIO IMPACT Webinar Series begins today with a look at sustainability accounting—get the details and join us at 1 PM ET!
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 166
  • 167
  • 168
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO